mRNA |
QS11 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.1 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.1 |
mRNA |
GSK4112 |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.1 |
mRNA |
CR-1-31B |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.1 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.1 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.1 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.1 |
mRNA |
SZ4TA2 |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.1 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.1 |